Home › Funds › Point72 Asset Management › NGNE
Point72 Asset Management position in NGNE
NEUROGENE INC · Health Care
Latest position (Q2 2026)141.92K sh
Reported value held$4.46M
Portfolio Weight0.01%
First reportedQ1 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 28.03K | $1.43M | New |
| Q1 2025 | 200.00K | $2.34M | New |
| Q3 2025 | 7.67K | $132.91K | New |
| Q2 2026 | 141.92K | $4.46M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NGNE
- Casdin Capital 1.55M sh · $48.60M · Q2 2026
- BlackRock Inc 1.06M sh · $33.27M · Q2 2026
- Balyasny Asset Management 818.71K sh · $25.75M · Q2 2026
- Citadel Advisors 435.68K sh · $13.70M · Q2 2026
- Vanguard Group 656.57K sh · $13.53M · Q4 2025
- Fidelity Management & Research (FMR) 295.56K sh · $9.30M · Q2 2026
- Geode Capital Management 293.18K sh · $9.22M · Q2 2026
- Franklin Resources 204.28K sh · $6.42M · Q2 2026
- Morgan Stanley 191.72K sh · $6.03M · Q2 2026
- UBS Group AG 171.29K sh · $5.39M · Q2 2026
- Moore Capital Management 141.64K sh · $4.45M · Q2 2026